X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-09-03 | CERS | Green Kevin Dennis | CFO | S - Sale | $2.16 | -82,657 | 536,093 | -13% | -$178,745 | |||||
2024-08-15 | CERS | Jensen Chrystal | GC | S - Sale | $2.07 | -16,667 | 474,245 | -3% | -$34,417 | ||||||
2024-08-02 | CERS | Benjamin Richard J | Chief Medical Officer | S - Sale | $2.50 | -21,605 | 438,007 | -5% | -$54,013 | ||||||
2024-05-13 | CERS | Shan Hua | Dir | P - Purchase | $1.99 | +2,500 | 32,386 | +8% | +$4,975 | ||||||
2024-05-10 | CERS | Nachtsheim Jami K | Dir | P - Purchase | $1.79 | +2,000 | 108,362 | +2% | +$3,578 | ||||||
2024-05-09 | CERS | Witney Frank | Dir | P - Purchase | $1.89 | +20,000 | 180,059 | +12% | +$37,800 | ||||||
2024-05-09 | CERS | Swisher Daniel N Jr | Dir | P - Purchase | $1.88 | +2,500 | 107,045 | +2% | +$4,689 | ||||||
| DM | 2024-03-13 | CERS | Green Kevin Dennis | CFO | S - Sale+OE | $1.99 | -42,555 | 618,750 | -6% | -$84,882 | |||||
| D | 2024-03-13 | CERS | Moore Carol | SVP Reg., Quality | S - Sale+OE | $2.02 | -20,619 | 490,623 | -4% | -$41,553 | |||||
| DM | 2024-03-13 | CERS | Jensen Chrystal | GC | S - Sale+OE | $2.02 | -35,284 | 490,912 | -7% | -$71,107 | |||||
| DM | 2024-03-13 | CERS | Jayaraman Vivek K | COO | S - Sale+OE | $2.02 | -53,041 | 878,653 | -6% | -$106,892 | |||||
| DM | 2024-03-13 | CERS | Greenman William Mariner | Pres, CEO | S - Sale+OE | $2.04 | -125,926 | 3,181,281 | -4% | -$256,377 | |||||
| DM | 2024-03-13 | CERS | Corash Laurence M | Chief Scientific Officer | S - Sale+OE | $2.02 | -28,427 | 2,339,740 | -1% | -$57,288 | |||||
| DM | 2024-03-13 | CERS | Benjamin Richard J | Chief Medical Officer | S - Sale+OE | $2.02 | -35,115 | 459,612 | -7% | -$70,766 | |||||
2024-03-08 | CERS | Benjamin Richard J | Chief Medical Officer | S - Sale | $2.40 | -29,378 | 478,061 | -6% | -$70,457 | ||||||
2023-12-13 | CERS | Bjerkholt Eric | Dir | P - Purchase | $1.62 | +10,000 | 142,133 | +8% | +$16,200 | ||||||
2023-08-22 | CERS | Lucena Ann | Dir | P - Purchase | $1.69 | +7,500 | 72,284 | +12% | +$12,638 | ||||||
2023-08-21 | CERS | Bjerkholt Eric | Dir | P - Purchase | $1.72 | +10,000 | 132,133 | +8% | +$17,151 | ||||||
2023-05-26 | CERS | Swisher Daniel N Jr | Dir | P - Purchase | $1.91 | +5,000 | 118,808 | +4% | +$9,535 | ||||||
2023-05-24 | CERS | Schulze Gail | Dir | P - Purchase | $2.03 | +9,850 | 83,420 | +13% | +$19,981 | ||||||
2023-05-23 | CERS | Bjerkholt Eric | Dir | P - Purchase | $2.00 | +5,000 | 82,133 | +6% | +$10,000 | ||||||
| D | 2023-03-13 | CERS | Moore Carol | SVP Reg., Quality | S - Sale+OE | $2.80 | -13,078 | 415,915 | -3% | -$36,618 | |||||
| D | 2023-03-13 | CERS | Jayaraman Vivek K | COO | S - Sale+OE | $2.80 | -25,356 | 658,070 | -4% | -$70,997 | |||||
| D | 2023-03-13 | CERS | Menard Chrystal | GC | S - Sale+OE | $2.80 | -15,468 | 349,530 | -4% | -$43,310 | |||||
| D | 2023-03-13 | CERS | Greenman William Mariner | Pres, CEO | S - Sale+OE | $2.80 | -60,480 | 2,658,346 | -2% | -$169,344 | |||||
| D | 2023-03-13 | CERS | Green Kevin Dennis | CFO | S - Sale+OE | $2.80 | -17,163 | 435,963 | -4% | -$48,056 | |||||
| D | 2023-03-13 | CERS | Corash Laurence M | Chief Scientific Officer | S - Sale+OE | $2.80 | -15,342 | 2,261,501 | -1% | -$42,958 | |||||
| D | 2023-03-13 | CERS | Benjamin Richard J | Chief Medical Officer | S - Sale+OE | $2.79 | -25,353 | 347,439 | -7% | -$70,781 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |